Nasdaq Suspends BNB Plus After Failed Treasury Strategy

BNB Plus Corp is officially off the Nasdaq exchange. The company, which previously operated under the name Applied DNA Sciences, faced suspension after its attempt to transform into a digital asset treasury went south. Shares plummeted by 99.99 percent on a split adjusted basis over the last three years, closing their final session on the exchange at just 16 cents.

The firm attempted a major pivot in September 2025, shifting its focus from DNA authentication technology to building a reserve of BNB tokens. Despite bringing on high profile advisors and raising millions in financing, the strategy failed to provide value to shareholders. The company has since been downlisted to the OTC Markets group while it pursues an appeal against the Nasdaq decision.

Management previously attempted to keep the stock price afloat through five separate reverse stock splits, but these efforts could not stop the downward slide. Currently, the company reports a market capitalization far below the value of its own crypto holdings, leading to a dismal net asset value ratio. With the business now contemplating a potential shift toward artificial intelligence, investors remain cautious about the future of this struggling entity.